2,206 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, HoldingsChannel.com reports. The firm acquired 2,206 shares of the company’s stock, valued at approximately $207,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Sigma Planning Corp grew its stake in GE HealthCare Technologies by 5.9% during the 3rd quarter. Sigma Planning Corp now owns 5,950 shares of the company’s stock worth $558,000 after buying an additional 330 shares during the last quarter. Covestor Ltd grew its stake in GE HealthCare Technologies by 48.9% during the 3rd quarter. Covestor Ltd now owns 920 shares of the company’s stock worth $86,000 after buying an additional 302 shares during the last quarter. Mesirow Financial Investment Management Inc. grew its stake in shares of GE HealthCare Technologies by 39.6% in the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after purchasing an additional 1,159 shares in the last quarter. Atria Investments Inc grew its stake in shares of GE HealthCare Technologies by 15.2% in the third quarter. Atria Investments Inc now owns 11,833 shares of the company’s stock worth $1,111,000 after purchasing an additional 1,565 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in shares of GE HealthCare Technologies by 14.0% in the third quarter. Lindbrook Capital LLC now owns 2,137 shares of the company’s stock worth $201,000 after purchasing an additional 263 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on GEHC. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research note on Wednesday, September 18th. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price target for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Trading Down 1.5 %

Shares of NASDAQ GEHC opened at $82.92 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $66.39 and a 12 month high of $94.55. The company has a market cap of $37.88 billion, a price-to-earnings ratio of 22.78, a P/E/G ratio of 3.05 and a beta of 1.24. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The business has a fifty day simple moving average of $88.76 and a 200-day simple moving average of $83.48.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same period in the prior year, the business posted $0.99 earnings per share. GE HealthCare Technologies’s revenue was up .9% compared to the same quarter last year. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is 3.30%.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.